Category: Press Release - Page 19 - Psychedelic Alpha

Read more about the article Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical Trial by Health Canada

Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical Trial by Health Canada

Post published:April 20, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial

Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial

Post published:April 20, 2023
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Post published:April 19, 2023
Post category:Press Release

Read more about the article Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders

Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders

Post published:April 19, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Post published:April 19, 2023
Post category:Press Release

Read more about the article Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023

Post published:April 17, 2023
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Notice of Allowance for Method of Use U.S. Patent Application

Algernon Pharmaceuticals Announces Notice of Allowance for Method of Use U.S. Patent Application

Post published:April 17, 2023
Post category:Press Release

Read more about the article Numinus Launches New Website to Enhance its Client Experience

Numinus Launches New Website to Enhance its Client Experience

Post published:April 14, 2023
Post category:Press Release

Read more about the article Numinus Wellness Inc. Reports Q2 2023 Results

Numinus Wellness Inc. Reports Q2 2023 Results

Post published:April 14, 2023
Post category:Press Release

Read more about the article atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

Post published:April 13, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.